Package 45802-104-01

Brand: olopatadine hydrochloride

Generic: olopatadine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 45802-104-01
Digits Only 4580210401
Product NDC 45802-104
Product ID 45802-104_dca15bfb-d84a-46e3-800c-3e3e1eaa6967
Description

1 BOTTLE in 1 CARTON (45802-104-01) / 240 SPRAY in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2017-06-14
Brand olopatadine hydrochloride
Generic olopatadine hydrochloride
Sample Package No

Linked Drug Pages (1)

olopatadine hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["NASAL"], "spl_id": "dca15bfb-d84a-46e3-800c-3e3e1eaa6967", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1797895"], "spl_set_id": ["126ff6eb-62ae-46f2-ab1e-7ac19346c36b"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (45802-104-01)  / 240 SPRAY in 1 BOTTLE", "package_ndc": "45802-104-01", "marketing_start_date": "20170614"}], "brand_name": "olopatadine hydrochloride", "product_id": "45802-104_dca15bfb-d84a-46e3-800c-3e3e1eaa6967", "dosage_form": "SPRAY", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "45802-104", "generic_name": "Olopatadine Hydrochloride", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "olopatadine hydrochloride", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "665 ug/1"}], "application_number": "ANDA202853", "marketing_category": "ANDA", "marketing_start_date": "20170614", "listing_expiration_date": "20261231"}